Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | KYNU | Q16719 | 2/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | FPR1 | P21462 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8291801 | 0.88 | HPGD (0.48) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL31369963 | 0.84 | ALPI (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL6631104 | 0.80 | HPGD (0.54) | SLC1A1SLC1A3SLC1A2HPGDCA1 | |
| SCHEMBL6631110 | 0.80 | HPGD (0.54) | SLC1A1SLC1A3SLC1A2HPGDCA1 | |
| SCHEMBL14215519 | 0.79 | HPGD (0.56) | SLC1A1SLC1A3SLC1A2HPGDCA1 | |
| SCHEMBL9574381 | 0.77 | HPGD (0.58) | SLC1A1SLC1A3SLC1A2HPGDCA1 | |
| SCHEMBL12527474 | 0.76 | EPHX1 (0.57) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL27413722 | 0.76 | CA1 (0.48) | SLC1A1SLC1A3SLC1A2HPGDCA1 | |
| SCHEMBL12491102 | 0.76 | EPHX1 (0.57) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL6734115 | 0.76 | SLC1A3 (0.59) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-5541290-A | OLIGOPEPTIDE CONTAINING ALPHA-KETOAMIDE GROUP, TREATMENT OF ALZHEIMER*S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS | CORTEX PHARMACEUTICALS, INC. | 1996-07-30 | — | — | US | claimed |
| WO-1995000535-A1 | OPTICALLY PURE CALPAIN INHIBITOR COMPOUNDS | ALKERMES, INCORPORATED (US) | 1995-01-05 | — | — | WO | claimed |
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | disclosed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-7517855-B2 | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | ATTENUON, LLC (US) | 2009-04-14 | — | — | US | disclosed |
| US-20040162239-A1 | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | ATTENUON LLC | 2004-08-19 | — | — | US | disclosed |
| US-5541290-A | OLIGOPEPTIDE CONTAINING ALPHA-KETOAMIDE GROUP, TREATMENT OF ALZHEIMER*S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS | CORTEX PHARMACEUTICALS, INC. | 1996-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040162239-A1 | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | HDGF, VIP, PGF | ALPI 1697/4885PKM 2171/4885PTGS1 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.